|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.760 USD | +5.63% |
|
+13.62% | -19.60% |
| Market Cap | 2.14B 1.86B 1.74B 1.59B 2.99B 204B 3.04B 20.39B 7.99B 102B 8.05B 7.87B 341B | P/E 2026 * |
-6.55x | P/E 2027 * | -7.01x |
|---|---|---|---|---|---|
| Enterprise Value | 1.77B 1.53B 1.43B 1.31B 2.46B 168B 2.5B 16.79B 6.58B 84.28B 6.63B 6.48B 281B | EV / Sales 2026 * |
33.4x | EV / Sales 2027 * | 20.3x |
| Free-Float |
99.07% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Ocular Therapeutix, Inc.
| 1 day | +5.63% | ||
| 1 week | +13.62% | ||
| Current month | +19.46% | ||
| 1 month | -4.31% | ||
| 3 months | +5.17% | ||
| 6 months | +6.55% | ||
| Current year | -19.60% |
| 1 week | 8.4 |  | 9.77 |
| 1 month | 8.15 | | 10.18 |
| Current year | 6.23 | | 13.03 |
| 1 year | 6.23 | | 16.44 |
| 3 years | 2 | | 16.44 |
| 5 years | 2 | | 16.44 |
| 10 years | 2 | | 24.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pravin Dugel
CEO | Chief Executive Officer | 62 | 15/04/2024 |
Jason Robins
DFI | Director of Finance/CFO | 50 | 20/01/2026 |
| Chief Tech/Sci/R&D Officer | - | 28/09/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Charles Warden
CHM | Chairman | 57 | 01/07/2019 |
| Director/Board Member | 78 | 05/11/2012 | |
Leslie Williams
BRD | Director/Board Member | 66 | 20/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23/02/26 | Sell | Executive/Senior Manager | 1,759 | 0.0008% | ||
| 23/02/26 | Sell | Executive/Senior Manager | 2,810 | 0.0013% | ||
| 23/02/26 | Sell | Chief Technology Officer | 3,057 | 0.0014% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.63% | +13.62% | -22.29% | +124.37% | 2.14B | |
| -1.37% | +8.90% | +91.28% | +130.00% | 1,083B | |
| -0.77% | +1.91% | +49.46% | +49.44% | 626B | |
| +0.85% | +2.58% | +25.90% | +64.34% | 442B | |
| -1.13% | +3.13% | +49.78% | +39.13% | 363B | |
| -0.74% | +1.01% | +31.08% | +38.64% | 295B | |
| -1.22% | +0.89% | +7.32% | +7.38% | 248B | |
| -0.70% | +6.23% | +45.32% | +57.82% | 224B | |
| +0.34% | -0.13% | -4.77% | -50.50% | 210B | |
| +2.04% | +0.38% | +12.70% | +69.71% | 168B | |
| Average | +0.29% | +1,497.21% | +28.58% | +53.03% | 366.13B | |
| Weighted average by Cap. | -0.61% | +1,331.60% | +49.59% | +66.09% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 52.93M 45.87M 42.94M 39.18M 73.74M 5.05B 74.98M 504M 197M 2.53B 199M 194M 8.43B | 102M 88.8M 83.14M 75.86M 143M 9.77B 145M 975M 382M 4.89B 385M 376M 16.32B |
| Net income | -334M -290M -271M -247M -466M -31.89B -474M -3.18B -1.25B -15.96B -1.26B -1.23B -53.24B | -324M -281M -263M -240M -452M -30.94B -459M -3.09B -1.21B -15.49B -1.22B -1.19B -51.67B |
| Net Debt | -378M -328M -307M -280M -527M -36.05B -535M -3.6B -1.41B -18.05B -1.42B -1.39B -60.2B | -66M -57.2M -53.54M -48.86M -91.94M -6.3B -93.48M -628M -246M -3.15B -248M -242M -10.51B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | $9.760 | +5.63% | 2,180,219 |
| 10/08/26 | $9.240 | +0.54% | 1,529,755 |
| 07/08/26 | $9.190 | +5.15% | 2,016,649 |
| 06/08/26 | $8.740 | +2.82% | 1,594,002 |
| 05/08/26 | $8.500 | -1.05% | 1,599,949 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCUL Stock
Select your edition
All financial news and data tailored to specific country editions
